ARTICLE | Company News
Axxam S.p.A. (Milan, Italy) said last month it partnered with Sanofi (Euronext:SAN; NYSE:SNY) to optimize lead small molecules, discovered by Axxam, in development to treat CNS diseases. Research will be performed at Sanofi and Axxam facilities. The pharma has an option to the programs...